227 related articles for article (PubMed ID: 14643404)
1. Antagonistic interactions among Fusobacterium nucleatum and Prevotella intermedia with oral lactobacilli.
Testa MM; Ruiz de Valladares R; Benito de Cardenas IL
Res Microbiol; 2003 Dec; 154(10):669-75. PubMed ID: 14643404
[TBL] [Abstract][Full Text] [Related]
2. Starvation response and growth in serum of Fusobacterium nucleatum, Peptostreptococcus anaerobius, Prevotella intermedia, and Pseudoramibacter alactolyticus.
Brundin M; Figdor D; Sundqvist G; Sjögren U
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):129-34. PubMed ID: 19540450
[TBL] [Abstract][Full Text] [Related]
3. Effects of oil drops containing Lactobacillus salivarius WB21 on periodontal health and oral microbiota producing volatile sulfur compounds.
Suzuki N; Tanabe K; Takeshita T; Yoneda M; Iwamoto T; Oshiro S; Yamashita Y; Hirofuji T
J Breath Res; 2012 Mar; 6(1):017106. PubMed ID: 22368259
[TBL] [Abstract][Full Text] [Related]
4. Bacterial antagonism against periodontopathogens.
van Essche M; Loozen G; Godts C; Boon N; Pauwels M; Quirynen M; Teughels W
J Periodontol; 2013 Jun; 84(6):801-11. PubMed ID: 22897652
[TBL] [Abstract][Full Text] [Related]
5. The aetiology and treatment of oral halitosis: an update.
Lee PP; Mak WY; Newsome P
Hong Kong Med J; 2004 Dec; 10(6):414-8. PubMed ID: 15591601
[TBL] [Abstract][Full Text] [Related]
6. Synergy in biofilm formation between Fusobacterium nucleatum and Prevotella species.
Okuda T; Kokubu E; Kawana T; Saito A; Okuda K; Ishihara K
Anaerobe; 2012 Feb; 18(1):110-6. PubMed ID: 21945879
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of Weissella cibaria isolates on the production of volatile sulphur compounds.
Kang MS; Kim BG; Chung J; Lee HC; Oh JS
J Clin Periodontol; 2006 Mar; 33(3):226-32. PubMed ID: 16489950
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial profiles of Prevotella spp. and Fusobacterium nucleatum isolated from periodontal infections in a selected area of southern Italy.
Mosca A; Miragliotta L; Iodice MA; Abbinante A; Miragliotta G
Int J Antimicrob Agents; 2007 Dec; 30(6):521-4. PubMed ID: 17954025
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial actions of benzimidazoles against the oral anaerobes Fusobacterium nucleatum and Prevotella intermedia.
Sheng J; Nguyen PT; Baldeck JD; Olsson J; Marquis RE
Arch Oral Biol; 2006 Nov; 51(11):1015-23. PubMed ID: 16806047
[TBL] [Abstract][Full Text] [Related]
10. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
[TBL] [Abstract][Full Text] [Related]
11. Acid tolerance and acid-neutralizing activity of Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum.
Takahashi N; Saito K; Schachtele CF; Yamada T
Oral Microbiol Immunol; 1997 Dec; 12(6):323-8. PubMed ID: 9573805
[TBL] [Abstract][Full Text] [Related]
12. Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli.
Ryan KA; Daly P; Li Y; Hooton C; O'Toole PW
J Antimicrob Chemother; 2008 Apr; 61(4):831-4. PubMed ID: 18263567
[TBL] [Abstract][Full Text] [Related]
13. Comparison of culture and real-time PCR for detection and quantification of five putative periodontopathogenic bacteria in subgingival plaque samples.
Jervøe-Storm PM; Koltzscher M; Falk W; Dörfler A; Jepsen S
J Clin Periodontol; 2005 Jul; 32(7):778-83. PubMed ID: 15966886
[TBL] [Abstract][Full Text] [Related]
14. Microflora in oral ecosystems in primary Sjögren's syndrome.
Almståhl A; Wikström M; Kroneld U
J Rheumatol; 2001 May; 28(5):1007-13. PubMed ID: 11361180
[TBL] [Abstract][Full Text] [Related]
15. Enhanced attachment of Porphyromonas gingivalis to human fibroblasts mediated by Fusobacterium nucleatum.
Metzger Z; Blasbalg J; Dotan M; Weiss EI
J Endod; 2009 Jan; 35(1):82-5. PubMed ID: 19084131
[TBL] [Abstract][Full Text] [Related]
16. Immune response to Fusobacterium nucleatum and Prevotella intermedia in patients with chronic maxillary sinusitis.
Brook I; Yocum P
Ann Otol Rhinol Laryngol; 1999 Mar; 108(3):293-5. PubMed ID: 10086624
[TBL] [Abstract][Full Text] [Related]
17. Dipeptide utilization by the periodontal pathogens Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens and Fusobacterium nucleatum.
Takahashi N; Sato T
Oral Microbiol Immunol; 2002 Feb; 17(1):50-4. PubMed ID: 11860556
[TBL] [Abstract][Full Text] [Related]
18. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity.
Kõll-Klais P; Mändar R; Leibur E; Marcotte H; Hammarström L; Mikelsaar M
Oral Microbiol Immunol; 2005 Dec; 20(6):354-61. PubMed ID: 16238595
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of Fusobacterium nucleatum biofilm formation by Porphyromonas gingivalis.
Saito Y; Fujii R; Nakagawa KI; Kuramitsu HK; Okuda K; Ishihara K
Oral Microbiol Immunol; 2008 Feb; 23(1):1-6. PubMed ID: 18173791
[TBL] [Abstract][Full Text] [Related]
20. Characterization of oral lactobacilli as potential probiotics for oral health.
Kõll P; Mändar R; Marcotte H; Leibur E; Mikelsaar M; Hammarström L
Oral Microbiol Immunol; 2008 Apr; 23(2):139-47. PubMed ID: 18279182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
